Director, Strategy Development

Overview

Sandoz is seeking a Director, Strategy Development to drive strategic insight generation, long-range planning, and enterprise prioritization within the North America Strategy & Growth organization. The role partners with the VP, Strategy & Growth to translate competitive, policy, and market dynamics into strategic implications and to develop the NA Strategic Roadmap as the unified source of regional strategic priorities. The position is located at the Princeton, NJ US Headquarters site with a flexible hybrid work approach for US office-based employees (up to 50% remote).

The role will not be remote-capable from other locations and requires authorized work eligibility in the U.S. U.S. work visa sponsorship is not available for this role now or in the future.

Within the North America Strategy & Growth organization, the Director, Strategy Development ensures a clean handoff from strategic choice to execution and collaborates with Corporate Communications to ensure accuracy of strategic messaging within the broader context of employee engagement.

Major Accountabilities / Your Key Responsibilities

Your responsibilities include, but are not limited to:

• External Ecosystem Evaluation & Strategic Implications

  Analyze competitive, policy, payer/provider, and macroeconomic trends shaping the North America healthcare and generics/biosimilars landscape.

• Generate forward-looking insights and strategic implications that inform enterprise decision-making.

• North America Strategic Roadmap

  Own the creation, evolution, and version control of the NA Strategic Roadmap as the authoritative source of long-term regional strategic priorities.

• Corporate Strategy Alignment

  Partner with Global Corporate Strategy to ensure regional priorities are harmonized with global enterprise strategy.

• Strategic Risk & Scenario Leadership

  Develop and lead scenario analyses, strategic risk models, and long-term enterprise assessments.

• Executive Decision Support

  Develop executive-ready strategy narratives, decision memos, and option evaluations.

• Special Projects & Strategic Initiatives

  Lead upstream, strategy-shaping projects such as whitespace analyses, long-range growth opportunities, competitive assessments, and enterprise strategic evaluations.

• Strategic Cross-Functional Partnership

  Engage senior functional leaders early in strategy formation to embed business realities and execution considerations.

Qualifications

Required Qualifications:

• Bachelor’s degree required; advanced degree (MBA, MPH, MS) strongly preferred.

• 8+ years in corporate strategy, management consulting, healthcare strategy, or related disciplines.

• Demonstrated experience producing executive-level strategic recommendations.

• Deep understanding of U.S. healthcare, pharmaceuticals, generics, and biosimilars.

• Experience operating in large, matrixed organizations and leading cross-functional initiatives.

• Exceptional communication, storytelling, and presentation skills.

• Proven ability to structure complex problems, synthesize insights, and navigate ambiguity.

Preferred Requirements:

• Experience in pharmaceuticals, generics, biosimilars, payer strategy, or healthcare consulting.

• Experience with Board-level or C-suite strategic engagements.

• Scenario planning, strategic risk, or portfolio strategy expertise.

Compensation & Benefits

The pay range for this position at commencement of employment is expected to be between $185,500 - 344,500 USD/year. The salary ranges are effective 1/1/26 through 12/31/26 and may be adjusted based on market factors. Final pay determinations depend on factors including location, experience, knowledge, skills, and abilities.

The total compensation may include a sign-on bonus, restricted stock units, discretionary awards, and a full range of benefits (medical, dental, vision, 401(k), paid time off, etc.). Details will be provided with an offer of employment. This is an at-will position, and the Company reserves the right to modify compensation programs at any time.

On September 30, 2021, Sandoz entered into a 5-year Corporate Integrity Agreement. Certain positions will have responsibilities to support CIA obligations and related audit or remediation activities.

Why Sandoz?

Generic and biosimilar medicines are the backbone of the global medicines industry. Sandoz is committed to expanding access to low-cost, high-quality medicines through investments in development capabilities, production sites, and partnerships. We offer a collaborative, hybrid work environment with opportunities for growth and diverse, inclusive experiences.